NYU Langone Health Bladder Cancer Symposium Update on Medical and Surgical Management for the Urologist 2021

10 $

‘+ Include: 17 videos, size: 1.05 GB

+ Target Audience: urologist, oncologist

Description

+ Include: 17 videos, size: 1.05 GB

+ Target Audience: urologist, oncologist

+ Sample video: contact me for sample video

+ Topics:

2021 Update on Advanced Urothelial Cancer Navigating 1L and Beyond Treatment Options.mp4
2021 Updates on Adjuvant MIBC DFS Data for Atezo vs. Observation, DFS & OS Data for ctDNA+ Patients.mp4
2021 Updates on Neoadjuvant MIBC MVAC Followed by RC, Accelerated MVAC, Dose-Dense MVAC + Pegfilgrastim, Checkpoint Inhibition IO.mp4
2021 Updates on Novel Therapies for HR-NMIBC Nadofaragene Firadenovec, CG0070+ -Pembro, EG-70.mp4
2021 Updates on Treatment, Surveillance, and Guidelines for NMIBC How to Perform Quality TURBT.mp4
BCG Shortage – Optimal Patient Selection, Alternatives, and “Upfront” RC for High-Risk NMIBC- How Useful Are Intravesical Chemotherapies How Can We Alter BCG Dosing Schedule.mp4
BCG Unresponsiveness and Intravesical Therapy in NMIBC Cost-Effectiveness Analysis of Salvage IT vs. Pembro.mp4
Expert Q&A Session and Case Discussion for Older Patients With MIBC Adjuvant PD-1 PD-L1 Therapy for High-Risk Disease, IO vs. Chemo vs. RC.mp4
High-Risk NMIBC Highlights Cytokine Therapy, ADCs, Drug Delivery Enhancement.mp4
Managing High-Risk NMIBC Options When BCG Is Not Effective.mp4
Open vs. Robotic Approaches in Radical Cystectomy Overview of Oncologic Outcomes.mp4
Quality Indicators and Enhanced Imaging in Cystoscopy and TURBT in NMIBC.mp4
Strategies for Organ Preservation in UC Why Remove Every Bad Bladder.mp4
Strategies for Radical Cystectomy Complications ERAS Guidelines, Prophylactic Antibiotics, Ureteral Strictures Management.mp4
Systemic Therapy for BCG Unresponsive NMIBC 1L IO in Cis-Ineligible mUC, Pembro for High-Risk Disease; Toxicity Concerns & QoL.mp4
Update on Upper Tract Urothelial Cell Carcinoma Distinguishing Features and Diagnosis, Mutational Profiling, Treatment Differences and Problems.mp4
Upper Tract Urothelial Cell Carcinoma Updates Endocavitary Treatment, Primary Chemoablation, Efficacy Data on Peri-Operative Chemo vs. Surveillance, (Neo)Adjuvant Chemo.mp4

Reviews

There are no reviews yet.

Be the first to review “NYU Langone Health Bladder Cancer Symposium Update on Medical and Surgical Management for the Urologist 2021”

Your email address will not be published. Required fields are marked *